Strong prediction of virological response to combination therapy by <i>IL28B</i> gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4

Abstract

In CHC genotype 4 patients, favourable genotypes of both SNPs of IL28B are valuable for predicting SVR. Additional genotyping of rs8099917 in carriers of the heterozygous C allele of rs12979860 can improve the prediction of SVR.